| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Sales Management > Sales Managers: Beware of The Latest Generation of Quack Sales Gurus |
|
Advice You - Sales Managers: Beware of The Latest Generation of Quack Sales Gurus
If I only had enough time or energy to dispel the latest and greate According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product st myths to pop-up in the sales game! I just happened upon another ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in canard: If your prospect is well qualified, you can be an utter idi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ot at selling and still make a living. I have a dog in my yard, a here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe earded Collie to be exact, who gets very hungry and if I starve him d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro long enough I think he’ll eat shoe leather. It’s obvious that if ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc omeone has a strong enough or urgent enough need, he’ll sell himsel easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi f. We call those prospects “walk-ins.” They, effectively speaking, nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically come to you. If you’re in a maturing or competitive business, ther and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ e aren’t that many “lay downs,” to find. Anyway, this bit of erran ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi wisdom is just another addition to the burgeoning literature of QU ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ACK SALES PRACTICES, or shall I say, malpractices. Espousers of thi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod drivel should be sued for malpractice! We can add to this list on cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e of my distinguished professors, someone who is the most quoted sa tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen e in management literature, the late Peter F. Drucker. He proclaime t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel d: “If you do a good enough job of marketing, selling becomes unne ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust essary.” This is simply a more intelligent, but also wrong way of y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products saying sell only to the qualified, to the ravenously hungry, to pro . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de pects that will close themselves. Baloney! Drucker got many thing elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip s right, but this piece of bull was WAY off the mark. Don’t buy it tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Setting Up Your Chart of Accounts Venture Capital Financing: Is It Within Your Reach? Warning - Pay Attention To Early Signals
|